Stock Analysis on Net
Stock Analysis on Net

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX)

This company has been moved to the archive! The financial data has not been updated since February 15, 2024.

Common-Size Balance Sheet: Assets

Vertex Pharmaceuticals Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 45.62 57.87 50.59 50.96 37.38
Marketable securities 3.74 1.51 5.43 5.71 8.40
Accounts receivable, net 6.88 7.95 8.46 7.53 7.62
Inventories 3.25 2.54 2.63 2.39 2.01
Tax-related prepaid and receivables 1.89 1.76 2.67 1.95 0.00
Prepaid expenses 0.48 0.62 0.62 0.00 0.00
Fair value of cash flow hedges 0.01 0.26 0.33 0.00 0.00
Other 0.37 0.41 0.44 0.68 2.57
Prepaid expenses and other current assets 2.74% 3.05% 4.06% 2.62% 2.57%
Current assets 62.23% 72.92% 71.18% 69.21% 57.98%
Property and equipment, net 5.10 6.11 8.15 8.16 8.96
Goodwill 4.79 5.99 7.46 8.53 12.05
Other intangible assets, net 3.70 3.33 2.98 3.40 4.81
Deferred tax assets 7.97 6.87 6.96 7.51 14.32
Operating lease assets 1.29 1.91 2.46 2.77 1.06
Long-term marketable securities 10.99 0.62 0.00 0.00 0.00
Other assets 3.94 2.26 0.82 0.42 0.83
Non-current assets 37.77% 27.08% 28.82% 30.79% 42.02%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Vertex Pharmaceuticals Inc. current assets as a percentage of total assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Vertex Pharmaceuticals Inc. property and equipment, net as a percentage of total assets decreased from 2021 to 2022 and from 2022 to 2023.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Vertex Pharmaceuticals Inc. non-current assets as a percentage of total assets decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.